News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
68 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39122)
2019 (51337)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42567)
2024 (37443)
2025 (33092)
2026 (3086)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (103)
2 (1)
4 (140)
5 (169)
6 (148)
7 (144)
8 (68)
9 (22)
10 (23)
11 (209)
12 (180)
13 (124)
14 (146)
15 (82)
17 (2)
18 (146)
19 (143)
20 (110)
21 (123)
22 (70)
24 (1)
25 (2)
26 (8)
27 (78)
28 (44)
29 (45)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
30
Business
What You Need to Know About Shepherd Therapeutics
There are many unusual things about Shepherd Therapeutics, but one of them is its origin.
December 8, 2017
·
4 min read
·
Mark Terry
Policy
Biotech Hedge Fund Titan, Isaly, Steps Down Amid Sexual Harassment Claims
In the wake of sexual harassment allegations, OrbiMed Advisors’ founder and managing partner Sam Isaly has stepped down from his position.
December 8, 2017
·
3 min read
·
Alex Keown
Business
WuXi Biologics Opens Expanded $150M Biomanufacturing Facility
Completed in two stages, the plant has begun operating fourteen 2,000 liter disposable bioreactors for fed-batch cell culture in the facility.
December 8, 2017
·
1 min read
Business
HighLife Names Former Biosensors CEO as Chairman of the Board
Pepe brings 30 years of experience in the medical device industry, having served in various executive and managerial roles at Biosensors, Abbott, Guidant and Eli Lilly.
December 8, 2017
·
3 min read
Drug Development
ARMO BioSciences Presents Efficacy Data From its Phase Ib Trial in Patients With Metastatic Renal Cell Carcinoma at ESMO Immuno-Oncology Congress 2017
ARMO BioSciences today announced additional clinical trial results on its lead investigational immuno-oncology drug AM0010 in metastatic renal cell carcinoma.
December 8, 2017
·
4 min read
Business
Synlogic and Ginkgo Bioworks Announce Collaboration as First Step Toward Building an Unprecedented Discovery Engine for Novel Living Medicines in Neurological and Liver Disorders
Together, Synlogic and Ginkgo aim to transform the discovery and design of living medicines.
December 8, 2017
·
6 min read
Pharm Country
Impax Receives Tentative FDA Approval of Generic Coreg CR (Carvedilol Phosphate) Extended-Release Capsules
The Company’s ANDA is eligible for final approval upon the expiration of marketing exclusivity on May 7, 2018.
December 8, 2017
·
5 min read
Drug Development
Encouraging Updated Results From Phase Ib/II Study Evaluating the Combination of Eribulin Mesylate and Pembrolizumab in Patients With Metastatic Triple-Negative Breast Cancer Presented at the 2017 SABCS
Findings presented during the 2017 SABCS showed the combination of eribulin and pembrolizumab resulted in an objective response rate of 26.4% the primary efficacy endpoint of the study.
December 8, 2017
·
10 min read
SGS Launches New Large Molecule Bioanalytical Services
SGS is now offering clients large molecule bioanalytical services at its laboratory in Wavre, Belgium.
December 8, 2017
·
2 min read
Business
Certara Introduces New Investigator Awards Program in Australia
Certara announced that Leigh Farrell, PhD, VP of Corporate Strategy and Business Development, is presenting the inaugural Certara New Investigator Awards in association with the ASCEPT.
December 8, 2017
·
3 min read
Previous
2 of 7
Next